PI
-
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial
Mocking, T. R., Haaksma, L. H., Reuvekamp, T., Kelder, A., Scholten, W. J., Ngai, L. L., Breems, D. A., Fischer, T., Gjertsen, B. T., Griškevičius, L., Juliusson, G., Maertens, J. A., Manz, M. G., Pabst, T., Passweg, J. R., Porkka, K., Valk, P. J. M., Gradowska, P., Löwenberg, B. & de Leeuw, D. C. & 5 others, , Oct 2025, In: Leukemia. 39, 10, p. 2559-2562 4 p.Research output: Contribution to journal › Article › Academic › peer-review
-
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
Apperley, J. F., Milojkovic, D., Cross, N. C. P., Hjorth-Hansen, H., Hochhaus, A., Kantarjian, H., Lipton, J. H., Malhotra, H., Niederwieser, D., Radich, J., Rousselot, P., Saussele, S., Schiffer, C. A., Silver, R., Soverini, S., Stenke, L., Turkina, A., Casado, L. F., Castagnetti, F. & Cervantes, F. & 18 others, , Aug 2025, In: Leukemia. 39, 8, p. 1797-1813 17 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study
Decker, T., Brucker, C., Engel, A., Fasching, P. A., Göhler, T., Jackisch, C., Janssen, J., Köhler, A., Lüdtke-Heckenkamp, K., Lüftner, D., Marmé, F., van Mackelenbergh, M., Rautenberg, B., Schmidt, M., Weide, R., Wimberger, P., Kisseleff, E., Pfister, C., Roos, C. & Wilhelm, N. & 1 others, , 1 Jun 2025, In: ESMO open. 10, 6, 105105.Research output: Contribution to journal › Article › Academic › peer-review
- All publications